- •Visual Prosthetics
- •Preface
- •Acknowledgments
- •Contents
- •Contributors
- •1.1 The Visual System as an Engineering Compromise
- •1.2 An Overview of Human Visual System Architecture
- •1.2.1 Architecture and Basic Function of the Eye
- •1.2.2 Layout of the Retino-Cortical Pathway
- •1.2.3 Layout of the Subcortical Pathways
- •1.3 An Overview of Human Visual Function
- •1.3.1 Roles of Central (Foveal) Vision
- •1.3.2 Roles of Peripheral Vision
- •1.3.3 Roles of Dark-Adapted Vision
- •1.3.4 A Few Remarks Regarding Visual Development
- •1.4 Prospects for Prosthetic Vision Restoration
- •References
- •2.1 Introduction
- •2.2 Retina
- •2.2.1 Anatomy
- •2.2.2 Physiology and Receptive Fields
- •2.4.1 Anatomy
- •2.4.2 Physiology and Receptive Fields
- •2.6 The Role of Spatiotemporal Edges in Early Vision
- •2.7 The Role of Corners in Early Vision
- •2.7.1 Overview
- •2.8 Effects of Fixational Eye Movements in Early Visual Physiology and Perception
- •2.8.1 Overview
- •2.8.2 Neural Adaptation and Visual Fading
- •2.8.3 Microsaccades in Visual Physiology and Perception
- •References
- •3.1 Introduction
- •3.2 Background
- •3.3 Retinal Disease and Its Diversity
- •3.4 Retinal Remodeling
- •3.5 Retinal Circuitry
- •3.6 Retinal Circuitry Revision
- •3.7 Implications for Bionic Rescue
- •3.8 Implications for Biological Rescue
- •3.9 Final Remarks
- •References
- •4.1 Introduction
- •4.4 What Are the Limits to This Cortical Plasticity?
- •4.5 Possible Mechanisms Behind Brain Plasticity
- •4.6 Modulation of Brain Plasticity: Recent Developments
- •4.7 Neuroplasticity and Other Neuroprostheses Efforts
- •4.8 A Look at What Is Ahead
- •References
- •5.1 Introduction
- •5.2 Vision Changes Experienced by RP Patients
- •5.2.1 Overview
- •5.2.2 Visual Field Loss in RP
- •5.2.3 Changes in Color Vision and Glare Sensitivity in RP
- •5.2.4 Vision Fluctuations in RP
- •5.3 Visual Changes in Patients with Advanced Macular Degeneration
- •5.3.1 Changes Due to Wet AMD or Choroidal Neovascularization
- •5.3.2 Changes Due to Dry AMD or Geographic Atrophy
- •5.4 Charles Bonnet Syndrome
- •5.4.1 Overview
- •5.4.2 Complexity of Visual Hallucinations in CBS
- •5.4.3 Predictors and Alleviating Factors for CBS
- •5.5 Filling-In Phenomena (Perceptual Completion)
- •5.6 Remapping of Primary Visual Cortex in Patients with Central Scotomas from Macular Disease
- •5.7 The Preferred Retinal Locus for Fixation
- •5.8 Photopsias
- •5.8.1 Photopsias in RP
- •5.8.2 Photopsias in AMD and Other Ocular Diseases
- •5.9 Concluding Remarks
- •References
- •6.1 Introduction
- •6.2 Electrode–Electrolyte Interface
- •6.3 Electrode Material
- •6.3.1 Electrode Characterization
- •6.4 Overview of Electrode Materials for Neural Stimulation
- •6.5 Overview of Extracellular Stimulation
- •6.6 Safe Stimulation of Tissue
- •6.6.1 Mechanisms of Neural Injury
- •6.6.2 Parameters for Safe Stimulation
- •6.6.3 Stimulation Induced Injury in the Retina
- •References
- •7.1 Introduction
- •7.2 Power and Data Transmission
- •7.2.1 Wireline Connection
- •7.2.2 Inductive Coils
- •7.2.3 Serial Optical Telemetry
- •7.2.4 Photodiode Array-Based Prostheses
- •7.2.5 Thermal Safety Considerations
- •7.2.6 Conclusions: Comparing the Different Approaches
- •7.3 Tissue Response to a Subretinal Implant
- •7.3.1 Flat Implants
- •7.3.2 Chamber Implants
- •7.3.3 Pillar Arrays
- •7.4 Damage to Retinal Tissue from Electrical Stimulation
- •7.4.1 Effect of Pulse Duration
- •7.4.2 Electrode Size
- •7.5 Concluding Remarks
- •References
- •8.1 Introduction
- •8.2 Quasistatic Numerical Methods: The Admittance Method
- •8.2.1 Layered Retinal Model
- •8.2.2 Equivalent Electric Circuit
- •8.3 Three-Dimensional Activation Function Calculation
- •8.4 Safety of Implant
- •8.5 Conclusion
- •References
- •9.1 Pathophysiology of Retinal Degeneration
- •9.2.1 Outer Plexiform Layer
- •9.2.2 Inner Plexiform Layer
- •9.2.2.1 Bipolar Cell Excitation of Retinal Ganglion Cells
- •9.2.2.2 Amacrine Cell Modulation of Signal Processing
- •9.2.2.3 Inhibitory Transmitters
- •9.2.2.4 Acetylcholine and Dopamine
- •9.2.2.5 Neuropeptides
- •9.2.2.6 Putative neurotransmitters for retinal prosthesis
- •9.3 Neurophysiological Changes in Retinal Degeneration
- •9.4 Rationale for a Neurotransmitter-Based Retinal Prosthesis
- •9.4.1 Limitations of Electrical Stimulation
- •9.5 Technical Considerations and Design Approaches
- •9.5.1 Operating Principles for a Neurotransmitter-Based Retinal Prosthesis
- •9.5.2 Establishing a Retinal Prosthesis/Synaptic Interface
- •9.5.2.1 The Proximity Requirement
- •9.5.2.2 Convective Delivery of Neurotransmitters Via Microfluidics
- •9.5.2.3 Functionalized Surfaces for Neurotransmitter Stimulation
- •9.5.2.4 Synaptic Requirements for l-Glutamate Mediated Neuronal Stimulation
- •9.6 Summary
- •References
- •10.1 Introduction
- •10.2 Pioneering Experiments
- •10.2.1 Stimulation with No Chromophores
- •10.2.2 Azo Chromophores
- •10.3 Current Research
- •10.3.1 Caged Neurotransmitters
- •10.3.2 Pore Blocker and Photoisomerization
- •10.3.3 The Channelrhodopsins
- •10.3.4 Melanopsin
- •10.4 Synthetic Chromophores and Artificial Sight
- •References
- •11.1 Background
- •11.2 Physical Structure of Intracortical Electrodes
- •11.3 Charge Injection Using Intracortical Electrodes
- •11.3.1 The Intracortical Electrode as a Transducer
- •11.3.2 Charge Injection Limits
- •11.4 Intracortical Electrode Coatings
- •11.5 Characterization of Intracortical Electrodes
- •11.5.1 Cyclic Voltammetry
- •11.5.2 Electrode Stimulation Voltage Waveforms
- •11.5.3 Non-ideal Access Resistance Behavior
- •11.5.4 Non-linear Electrode Polarization
- •11.5.5 Determining Electrode Safety
- •11.6 Contrasts of In Vitro and In Vivo Behavior
- •11.7 Alternative Coatings for Improving Intracortical Electrodes
- •11.7.1 SIROF
- •11.7.2 PEDOT
- •11.7.3 Carbon Nanotube Coatings
- •11.8 Conclusion
- •References
- •12.1 Introduction
- •12.2 Responses of RGCs to Electrical Stimulation in Normal Retina
- •12.2.1 Epiretinal Stimulation
- •12.2.1.1 Target of Stimulation
- •12.2.1.2 The Site of Spike Initiation in RGCs
- •12.2.1.3 Threshold vs. Stimulating Electrode Diameter
- •12.2.1.4 Spatial Extent of Activation
- •12.2.1.5 Selective Activation
- •12.2.1.6 Temporal Response Properties
- •12.2.2 Subretinal Stimulation
- •12.2.2.1 Target of Stimulation
- •12.2.2.2 Threshold vs. Polarity of Stimulation Pulse
- •12.2.2.3 Spatial Extent of Activation
- •12.2.2.4 Temporal Response Properties
- •12.2.2.5 Dynamics of the Retinal Response
- •12.4 Responses of RGCs to Electrical Stimulation in Degenerate Retina
- •12.4.1 Epiretinal Stimulation
- •12.4.2 Subretinal Stimulation
- •12.4.2.1 Response Properties of RGCs
- •12.4.2.2 Activation Thresholds of RGCs
- •12.5 Cortical Responses to Retinal Stimulation
- •12.5.1 Spatial Properties Revealed by Cortical Measurements
- •12.5.2 Local Field Potentials
- •12.5.3 Elicited Responses Are Focal
- •12.5.4 Cortical Measurements Reveal Electrode Interactions
- •12.5.5 Temporal Responsiveness in Cortex
- •12.6 Suggestions for Future Studies
- •References
- •13.1 Introduction
- •13.2 General Considerations for Acute Retinal Stimulation Experiments
- •13.3 Surgical Technique
- •13.4 Threshold Measurements
- •13.5 Spatial Resolution and Pattern Perception
- •13.6 Temporal Resolution
- •13.7 Subretinal Versus Epiretinal Stimulation
- •13.8 Less Invasive Stimulation Procedures
- •13.9 Conclusions and Outlook
- •References
- •14.1 Introduction
- •14.2 Overview of Chronic Retinal Implant Technologies
- •14.2.1 The Retinal Implant AG Microphotodiode Prosthesis
- •14.2.2 The Intelligent Retinal Implant System
- •14.2.3 Second Sight Medical Products, Inc. A16 System
- •14.3 Thresholds on Individual Electrodes
- •14.3.1 Single Pulse Thresholds Using the SSMP System
- •14.3.2 Pulse Train Integration and Temporal Sensitivity
- •14.4 Suprathreshold Brightness
- •14.4.1 Brightness Using the Retinal Implant AG System
- •14.4.2 Brightness Using the Intelligent Medical Implant System
- •14.4.3 Brightness Using the SSMP A16 System
- •14.5 Spatial Vision
- •14.5.1 Spatial Vision with the Retinal Implant AG System
- •14.5.2 Spatial Vision with the Intelligent Medical Implant System
- •14.5.3 Spatial Vision with the SSMP A16 System
- •14.6 Models to Guide Electrical Stimulation Protocols
- •14.7 Conclusions
- •References
- •15.1 Background
- •15.2 Cortical Surface Stimulation
- •15.3 Intracortical Microstimulation
- •15.4 Optic Nerve Stimulation
- •15.5 What Is Known and What Needs to Be Done
- •15.6 Current Research Efforts
- •15.6.1 Optic Nerve Stimulation
- •15.6.2 Cortical Surface Stimulation
- •15.6.3 Intracortical Stimulation of Visual Cortex
- •15.6.4 CORTIVIS Program
- •15.6.5 Lateral Geniculate Stimulation
- •15.7 Microelectrode Arrays and Stimulation Hardware
- •15.7.1 Miniature Cameras
- •15.7.2 Animal Models
- •15.7.3 Image Processing and Phosphene Mapping
- •15.8 Conclusion
- •References
- •16.1 Introduction
- •16.2 Simulation Techniques and Basic Parameters
- •16.2.1 Gaze Tracking and Image Stabilization
- •16.2.2 Filter Engine Parameters
- •16.2.2.1 Raster Spatial Properties
- •16.2.2.2 Dot Spatial Properties
- •16.2.2.3 Temporal Properties
- •16.2.2.4 Dynamic Background Noise
- •16.2.2.5 Input Filtering/Windowing, Image Enhancement
- •16.3 Optotype Resolution and Reading
- •16.3.1 Visual Acuity
- •16.3.2 Reading
- •16.4 Face and Object Recognition
- •16.5 Visually Guided Behavior
- •16.5.1 Hand–Eye Coordination
- •16.5.2 Wayfinding
- •16.6 Visual Tracking
- •16.7 Computational Simulations
- •16.8 Conclusion
- •References
- •17.1 Introduction
- •17.2 Situating Image Analysis
- •17.3 The Experimental Framework
- •17.4 Tracking a Low-Resolution Target
- •17.5 Discussion
- •17.6 Conclusion
- •References
- •18.1 Introduction
- •18.2 Representation of Visual Space on the Visual Cortex
- •18.3 Cortical Stimulation Studies
- •18.4 Variability in Occipital Cortex
- •18.5 Phosphene Map Estimation
- •18.6 Psychophysical Studies with the Estimated Maps
- •References
- •19.1 Importance of Mapping
- •19.3 The Computer Era: Refining the Pointing Method of Phosphene Mapping
- •19.4 Verbal Mapping
- •19.5 Mapping Studies Using Subject Drawings
- •19.6 Recent Simulation Studies Using Phosphene Mapping
- •19.6.1 Tactile Simulations at Shanghai Jiao Tong University
- •19.6.2 Simulations in Our Laboratory
- •19.7 Concluding Remarks on Phosphene Mapping Techniques
- •References
- •20.1 Introduction
- •20.2 Principles for Assessment of Prosthetic Vision
- •20.2.1 Experimental Design
- •20.2.2 The Importance of Pre-operative Testing
- •20.2.3 Post-operative Assessment
- •20.2.4.1 Potential Approaches
- •20.2.4.2 Avoidance of Bias
- •20.2.4.3 Criteria for Sound Testing
- •20.2.4.4 Forced Choice Procedures
- •20.2.4.5 Response Time
- •20.2.4.6 Task (Perceptual) Learning
- •20.2.4.7 Establishing Criteria for Meaningful Change
- •20.2.4.8 Light Level
- •20.3 Vision Assessment in Prosthesis Recipients: Overview
- •20.3.1 Visual Function Assessment: Overview
- •20.3.2 Visual Performance Assessment: Overview
- •20.3.2.1 Measured Visual Performance
- •20.3.2.2 Self-Reported Visual Performance
- •20.4 Visual Function Assessment
- •20.4.1 Candidate Measures
- •20.4.1.1 Contrast Sensitivity (Contrast Detection)
- •20.4.1.2 Contrast Discrimination
- •20.4.1.3 Motion Perception
- •20.4.1.4 Depth Perception
- •20.4.2 Tests Used in Prosthesis Trials
- •20.4.3 Tests that Have Been Designed for Use with Prostheses
- •20.4.4 Vision Tests for Very Low Vision
- •20.5 Visual Performance Assessment
- •20.5.1 Measured Performance
- •20.5.2 Self-Reported Performance (Questionnaires)
- •20.6 Summary
- •References
- •21.1 Concepts of Functional Vision and Rehabilitation
- •21.1.1 Application to Orientation and Mobility
- •21.1.2 Application for Activities of Daily Living
- •21.1.3 Patient Lifestyle and Expectations
- •21.1.4 Congenital and Adventitious Vision Loss
- •21.2 Evaluation and Intervention with Prosthetic Vision
- •21.2.1 Evaluation
- •21.2.2 Intervention
- •21.3 Measuring Functional Outcomes
- •21.4 The Future
- •References
- •Author Index
- •Subject Index
4 Cortical Plasticity and Reorganization in Severe Vision Loss |
87 |
pathway [31]. These neuroanatomical and physiological changes also need to be taken into consideration in terms of the effects of chronic electrical stimulation and the potential long term benefits.
4.8 A Look at What Is Ahead
The lessons to be learned are that simple re-introduction of the lost sensory input by itself might not be sufficient to restore the lost sense. For restoring functional vision in the blind, we must first understand how the brain adapts to blindness and uncover adaptive resources such as cross-modal representations. There is no doubt that plasticity will contribute to the success of any visual neuroprostheses, but specific strategies will then be necessary to modulate information processing by the brain and to extract relevant and functionally meaningful information from the electrical stimulation patterns [33, 61, 62] (Fig. 4.5).
Fig. 4.5 Some possible experimental strategies proposed to enhance functional vision and the adaptation to a visual neuroprosthetic device. It should be taken into account that the rehabilitation of the blind is a very complex problem, requiring intimate collaborations among clinicians, basic scientists, engineers, educators and rehabilitative experts
88 |
E. Fernández and L.B. Merabet |
Several studies have highlighted that following the loss of vision the brain undergoes profound neuroplastic changes. This plasticity takes place at a variety of levels, from the synaptic interactions among single neurons and the circuits in which neurons interact, to large-scale systems comprising those circuits. Furthermore it has been also suggested that glial cells could have central roles in the adaptation to blindness [13]. The precise understanding of these changes will be crucial in developing and projecting the success of novel visual neuroprosthetic strategies will certainly have implications for rehabilitative training and device development. This endeavor will require strong interactions between basic scientists, clinicians, engineers and rehabilitation experts to help make decisions about (a) whether potentially residual capacity for vision exists; (b) how this plasticity can be driven and (c) what the inputs should be to maximize this restitution. These issues are central to the development of any visual neuroprosthesis approach and will provide a mechanistic rationale for understanding therapeutic interventions and teaching strategies for the blind.
New evidence about experience-dependent plasticity of the adult brain together with the achievements of other neuroprosthesis efforts allows cautious optimism about the possibility to restore some functional vision to profoundly blind individuals, but there are still several important issues that should be taken into account. Case studies of surgical sight restoration following long-term visual deprivation [35, 39] provide a relevant insight. For example, patients blinded for many years experience profound difficulty in various visual tasks, particularly those requiring the identification and recognition of objects following ocular surgical procedures aimed at regaining some degree of functional vision. Interestingly, if these patients were allowed to explore the same object through touch, they can recognize it immediately as to register their newly acquired visual percepts with their existing senses. These results suggest that the simple restoration of the lost sensory input may not itself suffice for achieving a functional sense. One possibility to overcome this problem might be to develop a patient controlled system that coordinates and registers the visual perceptions generated by a visual prosthesis with the identification of objects perceived through other senses (such as touch and audition). Patients could then learn to integrate these concordant sources of sensory stimuli into meaningful percepts [61].
Finally, although the effects of neural plasticity are prominent in the context of any visual neuroprosthesis, they are usually unrecognized or greatly underestimated. Therefore, it is essential that future research explore the mechanisms that underlie brain plasticity following the loss of vision and that research studies in the field of visual prosthesis learn to integrate these new findings to enhance the translation of this knowledge to clinical research and practice. We have now an unprecedented number of tools for the restoration of sight through artificial means but we have to use these tools to select appropriate candidates for implantation, to develop suitable rehabilitative strategies for each particular type of visual neuroprosthesis and to achieve the best possible behavioral outcome for a given person using these devices.
4 Cortical Plasticity and Reorganization in Severe Vision Loss |
89 |
References
1.Adachi K, Lee JC, Hu JW, et al. (2007), Motor cortex neuroplasticity associated with lingual nerve injury in rats. Somatosens Mot Res, 24(3): p. 97–109.
2.Alfaro A, Concepcion L, Merabet L, Fernandez E (2006), An atypical presentation of visual hallucinatory experiences following prolonged blindness. Neurocase, 12(4): p. 212–5.
3.Alonso-Alonso M, Fregni F, Pascual-Leone A (2007), Brain stimulation in poststroke rehabilitation. Cerebrovasc Dis, 24(Suppl 1): p. 157–66.
4.Amedi A, Floel A, Knecht S, et al. (2004), Transcranial magnetic stimulation of the occipital pole interferes with verbal processing in blind subjects. Nat Neurosci, 7(11): p. 1266–70.
5.Amedi A, Raz N, Pianka P, et al. (2003), Early ‘visual’ cortex activation correlates with superior verbal memory performance in the blind. Nat Neurosci, 6(7): p. 758–66.
6.Anderson SW, Rizzo M (1994), Hallucinations following occipital lobe damage: the pathological activation of visual representations. J Clin Exp Neuropsychol, 16(5): p. 651–63.
7.Bach-y-Rita P (2004), Tactile sensory substitution studies. Ann N Y Acad Sci, 1013: p. 83–91.
8.Baker CI, Peli E, Knouf N, Kanwisher NG (2005), Reorganization of visual processing in macular degeneration. J Neurosci, 25(3): p. 614–8.
9.Bao S, Chan VT, Merzenich MM (2001), Cortical remodelling induced by activity of ventral tegmental dopamine neurons. Nature, 412(6842): p. 79–3.
10. Barbay S, Zoubina EV, Dancause N, et al. (2006), A single injection of d-amphetamine facilitates improvements in motor training following a focal cortical infarct in squirrel monkeys. Neurorehabil Neural Repair, 20(4): p. 455–8.
11. Barker AT, Jalinous R, Freeston IL (1985), Non-invasive magnetic stimulation of human motor cortex. Lancet, 1: p. 1106–7.
12. Bavelier D, Neville HJ (2002), Cross-modal plasticity: where and how? Nat Rev Neurosci, 3(6): p. 443–52.
13. Bernabeu A, Alfaro A, Garcia M, Fernandez E (2009), Proton magnetic resonance spectroscopy (1H-MRS) reveals the presence of elevated myo-inositol in the occipital cortex of blind subjects. Neuroimage, 47(4): p. 1172–6.
14. Bouccara D, Avan P, Mosnier I, et al. (2005), Auditory rehabilitation. Med Sci (Paris), 21(2): p. 190–7.
15. Breitenstein C, Wailke S, Bushuven S, et al. (2004), d-Amphetamine boosts language learning independent of its cardiovascular and motor arousing effects. Neuropsychopharmacology,
29(9): p. 1704–14.
16. Buonomano DV, Merzenich MM (1998), Cortical plasticity: from synapses to maps. Annu Rev Neurosci, 21: p. 149–86.
17. Burton H, Snyder AZ, Conturo TE, et al. (2002), Adaptive changes in early and late blind: a fMRI study of Braille reading. J Neurophysiol, 87(1): p. 589–607.
18. Cajal SR (1904), Textura del sistema nervioso del hombre y de los vertebrados. Imprenta y librería de Nicolás Moya: Madrid.
19. Calford MB, Chino YM, Das A, et al. (2005), Neuroscience: rewiring the adult brain. Nature, 438(7065): p. E3; discussion E3–4.
20. Celesia GG (2005), Visual plasticity and its clinical applications. J Physiol Anthropol Appl Human Sci, 24(1): p. 23–7.
21. Celnik P, Hummel F, Harris-Love M, et al. (2007), Somatosensory stimulation enhances the effects of training functional hand tasks in patients with chronic stroke. Arch Phys Med Rehabil, 88(11): p. 1369–76.
22. Cheung SH, Legge GE (2005), Functional and cortical adaptations to central vision loss. Vis Neurosci, 22(2): p. 187–201.
23. Cogan DG (1973), Visual hallucinations as release phenomena. Albrecht Von Graefes Arch Klin Exp Ophthalmol, 188(2): p. 139–50.
90 |
E. Fernández and L.B. Merabet |
24. Cohen LG, Celnik P, Pascual-Leone A, et al. (1997), Functional relevance of cross-modal plasticity in blind humans. Nature, 389(6647): p. 180–3.
25. Cohen LG, Ziemann U, Chen R, et al. (1998), Studies of neuroplasticity with transcranial magnetic stimulation. J Clin Neurophysiol, 15(4): p. 305–24.
26. Dagnelie G (2006), Visual prosthetics 2006: assessment and expectations. Expert Rev Med Devices, 3(3): p. 315–25.
27. Dilks DD, Serences JT, Rosenau BJ, et al. (2007), Human adult cortical reorganization and consequent visual distortion. J Neurosci, 27(36): p. 9585–94.
28. Dreher B, Burke W, Calford MB (2001), Cortical plasticity revealed by circumscribed retinal lesions or artificial scotomas. Prog Brain Res, 134: p. 217–46.
29. Duque J, Mazzocchio R, Stefan K, et al. (2008), Memory formation in the motor cortex ipsilateral to a training hand. Cereb Cortex, 18: p. 1395–406.
30. Dyck RH, Chaudhuri A, Cynader MS (2003), Experience-dependent regulation of the zincergic innervation of visual cortex in adult monkeys. Cereb Cortex, 13(10): p. 1094–109.
31. Fallon JB, Irvine DR, Shepherd RK (2008), Cochlear implants and brain plasticity. Hear Res, 238(1–2): p. 110–7.
32. Fernandez E, Alfaro A, Tormos JM, et al. (2002), Mapping of the human visual cortex using image-guided transcranial magnetic stimulation. Brain Res Protoc, 10: p. 115–24.
33. Fernandez E, Pelayo F, Romero S, et al. (2005), Development of a cortical visual neuroprosthesis for the blind: the relevance of neuroplasticity. J Neural Eng, 2(4): p. R1–12.
34. Ferrandez JM, Alfaro A, Bonomini P, et al. (2003), Brain plasticity: feasibility of a cortical visual prosthesis for the blind. In Engineering in Medicine and Biology Society. Proceedings of the 25th Annual International Conference of the IEEE.
35. Fine I, Wade AR, Brewer AA, et al. (2003), Long-term deprivation affects visual perception and cortex. Nat Neurosci, 6(9): p. 915–6.
36. Finney EM, Fine I, Dobkins KR (2001), Visual stimuli activate auditory cortex in the deaf. Nat Neurosci, 4(12): p. 1171–3.
37. Froemke RC, Merzenich MM, Schreiner CE (2007), A synaptic memory trace for cortical receptive field plasticity. Nature, 450(7168): p. 425–9.
38. Gizewski ER, Gasser T, de Greiff A, et al. (2003), Cross-modal plasticity for sensory and motor activation patterns in blind subjects. Neuroimage, 19(3): p. 968–75.
39. Gregory RL (2003), Seeing after blindness. Nat Neurosci, 6(9): p. 909–10.
40. Hamilton R, Keenan JP, Catala M, Pascual-Leone A (2000), Alexia for Braille following bilateral occipital stroke in an early blind woman. Neuroreport, 11(2): p. 237–40.
41. Hebb DO (1947), The effects of early experience on problem solving at maturity. Am Psychol,
2: p. 737–45.
42. Hernandez Muela S, Mulas F, Mattos L (2004), Functional neuronal plasticity. Rev Neurol, 38(Suppl 1): p. 58–68.
43. Hummel FC, Cohen LG (2005), Drivers of brain plasticity. Curr Opin Neurol, 18(6): p. 667–74.
44. Hummel FC, Cohen LG (2006), Non-invasive brain stimulation: a new strategy to improve neurorehabilitation after stroke? Lancet Neurol, 5(8): p. 708–12.
45. Iwai Y, Fagiolini M, Obata K, Hensch TK (2003), Rapid critical period induction by tonic inhibition in visual cortex. J Neurosci, 23(17): p. 6695–702.
46. Johansson BB (2000), Brain plasticity and stroke rehabilitation. The Willis lecture. Stroke,
31(1): p. 223–30.
47. Kaas JH (2002), Sensory loss and cortical reorganization in mature primates. Prog Brain Res,
138: p. 167–76.
48. Kaas JH, Krubitzer LA, Chino YM, et al. (1990), Reorganization of retinotopic cortical maps in adult mammals after lesions of the retina. Science, 248(4952): p. 229–31.
49. Komitova M, Johansson BB, Eriksson PS (2006), On neural plasticity, new neurons and the postischemic milieu: an integrated view on experimental rehabilitation. Exp Neurol, 199(1): p. 42–55.
4 Cortical Plasticity and Reorganization in Severe Vision Loss |
91 |
50. Kral A, Tillein J, Heid S, et al. (2006), Cochlear implants: cortical plasticity in congenital deprivation. Prog Brain Res, 157: p. 283–313.
51. Kujala T, Alho K, Paavilainen P, et al. (1992), Neural plasticity in processing of sound location by the early blind: an event-related potential study. Electroencephalogr Clin Neurophysiol,
84(5): p. 469–72.
52. Lee DS, Lee JS, Oh SH, et al. (2001), Cross-modal plasticity and cochlear implants. Nature, 409(6817): p. 149–50.
53. Loeb GE (1990), Cochlear prosthetics. Annu Rev Neurosci, 13: p. 357–71.
54.Maeda K, Yasuda H, Haneda M, Kashiwagi A (2003), Braille alexia during visual hallucination in a blind man with selective calcarine atrophy. Psychiatry Clin Neurosci, 57(2): p. 227–9.
55. Mahncke HW, Bronstone A, Merzenich MM (2006), Brain plasticity and functional losses in the aged: scientific bases for a novel intervention. Prog Brain Res, 157: p. 81–109.
56. Mahncke HW, Connor BB, Appelman J, et al. (2006), Memory enhancement in healthy older adults using a brain plasticity-based training program: a randomized, controlled study. Proc Natl Acad Sci USA, 103(33): p. 12523–8.
57. Manford M, Andermann F (1998), Complex visual hallucinations. Clinical and neurobiological insights. Brain, 121(Pt 10): p. 1819–40.
58. Masuda Y, Dumoulin SO, Nakadomari S, Wandell BA (2008), V1 projection zone signals in human macular degeneration depend on task, not stimulus. Cereb Cortex, 18: p. 2483–93.
59. McDermott HJ (2004), Music perception with cochlear implants: a review. Trends Amplif,
8(2): p. 49–82.
60. Merabet LB, Pascual-Leone A (2010), Neural reorganization following sensory loss: the opportunity of change. Nat Rev Neurosci, 11(1): p. 44–52.
61. Merabet LB, Rizzo JF, Amedi A, et al. (2005), What blindness can tell us about seeing again: merging neuroplasticity and neuroprostheses. Nat Rev Neurosci, 6(1): p. 71–7.
62. Merabet LB, Rizzo JF, III, Pascual-Leone A, Fernandez E (2007), ‘Who is the ideal candidate?’: decisions and issues relating to visual neuroprosthesis development, patient testing and neuroplasticity. J Neural Eng, 4(1): p. S130–5.
63. Merabet L, Thut G, Murray B, et al. (2004), Feeling by sight or seeing by touch? Neuron, 42(1): p. 173–9.
64. Middlebrooks JC, Bierer JA, Snyder RL (2005), Cochlear implants: the view from the brain. Curr Opin Neurobiol, 15(4): p. 488–93.
65. Mitchell TV, Maslin MT (2007), How vision matters for individuals with hearing loss. Int J Audiol, 46(9): p. 500–11.
66. Nair DG, Hutchinson S, Fregni F, et al. (2007), Imaging correlates of motor recovery from cerebral infarction and their physiological significance in well-recovered patients. Neuroimage,
34(1): p. 253–63.
67. Normann RA, Maynard E, Guillory KS, Warren DJ (1996), Cortical implants for the blind. IEEE Spectrum, 33(5): p. 54–9.
68. Nudo RJ (2003), Adaptive plasticity in motor cortex: implications for rehabilitation after brain injury. J Rehabil Med, 41(Suppl): p. 7–10.
69. Nudo RJ (2003), Functional and structural plasticity in motor cortex: implications for stroke recovery. Phys Med Rehabil Clin N Am, 14(1 Suppl): p. S57–76.
70. Nudo RJ (2006), Plasticity. NeuroRx, 3(4): p. 420–7.
71. Nudo RJ, Jenkins WM, Merzenich MM (1990), Repetitive microstimulation alters the cortical representation of movements in adult rats. Somatosens Mot Res, 7(4): p. 463–83.
72. Pascual-Leone A, Amedi A, Fregni F, Merabet LB (2005), The plastic human brain cortex. Annu Rev Neurosci, 28: p. 377–401.
73. Pascual-Leone A, Hamilton R, Tormos JM, et al. (1999), Neuroplasticity in the adjustment to blindness. In Neuronal Plasticity: Building a Bridge from the Laboratory to the Clinic, J. Grafman, Christen Y, Editors. Springer: Berlin.
74. Pena C, Bowsher K, Samuels-Reid J (2004), FDA-approved neurologic devices intended for use in infants, children, and adolescents. Neurology, 63(7): p. 1163–7.
92 |
E. Fernández and L.B. Merabet |
75. Plautz EJ, Barbay S, Frost SB, et al. (2003), Post-infarct cortical plasticity and behavioral recovery using concurrent cortical stimulation and rehabilitative training: a feasibility study in primates. Neurol Res, 25(8): p. 801–10.
76. Ptito M, Kupers R (2005), Cross-modal plasticity in early blindness. J Integr Neurosci, 4(4): p. 479–88.
77. Ptito M, Moesgaard SM, Gjedde A, Kupers R (2005), Cross-modal plasticity revealed by electrotactile stimulation of the tongue in the congenitally blind. Brain, 128(Pt 3): p. 606–14.
78. Ramos-Estebanez C, Merabet LB, Machii K, et al. (2007), Visual phosphene perception modulated by subthreshold crossmodal sensory stimulation. J Neurosci, 27(15): p. 4178–81.
79. Rauschecker JP (1995), Compensatory plasticity and sensory substitution in the cerebral cortex. Trends Neurosci, 18(1): p. 36–43.
80. Roder B, Stock O, Bien S, et al. (2002), Speech processing activates visual cortex in congenitally blind humans. Eur J Neurosci, 16(5): p. 930–6.
81. Roder B, Teder-Salejarvi W, Sterr A, et al. (1999), Improved auditory spatial tuning in blind humans. Nature, 400(6740): p. 162–6.
82. Sadato N, Pascual-Leone A, Grafman J, et al. (1996), Activation of the primary visual cortex by Braille reading in blind subjects. Nature, 380(6574): p. 526–8.
83. Sadato N, Pascual-Leone A, Grafman J, et al. (1998), Neural networks for Braille reading by the blind. Brain, 121(Pt 7): p. 1213–29.
84. Shaw KN, Commins S, O’Mara SM (2003), Deficits in spatial learning and synaptic plasticity induced by the rapid and competitive broad-spectrum cyclooxygenase inhibitor ibuprofen are reversed by increasing endogenous brain-derived neurotrophic factor. Eur J Neurosci, 17(11): p. 2438–46.
85. Shaw CA, Lanius RA, van den Doel K (1994), The origin of synaptic neuroplasticity: crucial molecules or a dynamical cascade? Brain Res Brain Res Rev, 19(3): p. 241–63.
86. Smirnakis SM, Brewer AA, Schmid MC, et al. (2005), Lack of long-term cortical reorganization after macaque retinal lesions. Nature, 435(7040): p. 300–7.
87.Sonde L, Lokk J (2007), Effects of amphetamine and/or l-dopa and physiotherapy after stroke – a blinded randomized study. Acta Neurol Scand, 115(1): p. 55–9.
88. Stroemer RP, Kent TA, Hulsebosch CE (1998), Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with d-amphetamine therapy after neocortical infarction in rats. Stroke, 29(11): p. 2381–93; discussion 2393–5.
89. Thickbroom GW (2007), Transcranial magnetic stimulation and synaptic plasticity: experimental framework and human models. Exp Brain Res, 180(4): p. 583–93.
90. Uhl F, Franzen P, Lindinger G, et al. (1991), On the functionality of the visually deprived occipital cortex in early blind persons. Neurosci Lett, 124(2): p. 256–9.
91. Uhl F, Franzen P, Podreka I, et al. (1993), Increased regional cerebral blood flow in inferior occipital cortex and cerebellum of early blind humans. Neurosci Lett, 150(2): p. 162–4.
92. Van Boven RW, Hamilton RH, Kauffman T, et al. (2000), Tactile spatial resolution in blind Braille readers (1). Am J Ophthalmol, 130(4): p. 542.
93. Weeks R, Horwitz B, Aziz-Sultan A, et al. (2000), A positron emission tomographic study of auditory localization in the congenitally blind. J Neurosci, 20(7): p. 2664–72.
94. Whiting E, Chenery HJ, Chalk J, Copland DA (2007), Dexamphetamine boosts naming treatment effects in chronic aphasia. J Int Neuropsychol Soc, 13(6): p. 972–9.
95. Zepeda A, Sengpiel F, Guagnelli MA, et al. (2004), Functional reorganization of visual cortex maps after ischemic lesions is accompanied by changes in expression of cytoskeletal proteins and NMDA and GABA(A) receptor subunits. J Neurosci, 24(8): p. 1812–21.
96.Zhou X, Merzenich MM (2007), Intensive training in adults refines A1 representations degraded in an early postnatal critical period. Proc Natl Acad Sci USA, 104(40): p. 15935–40.
Chapter 5
Visual Perceptual Effects of Long-Standing
Vision Loss
Ava K. Bittner and Janet S. Sunness
Abstract This chapter focuses on the changes in vision experienced by patients with RP and AMD. The specific aspects of vision that are reviewed include progressive changes in central acuity, contrast sensitivity, visual field, color vision, night vision, glare, and light and dark adaptation. Emphasis is on patients’ perspectives, including the impact on functioning and performance of activities of daily living, as well as rates, patterns of vision loss, and day-to-day visual fluctuations experienced by those with retinal degenerative diseases. Several types of visual phenomena are presented, including Charles Bonnet Syndrome hallucinations in AMD, perceptual completion or filling-in of scotomas in AMD, remapping visual cortex in AMD, the preferred retinal locus in AMD, and photopsias or light show type flashes in RP. The proposed implications of these visual changes and phenomena as they apply to retinal prosthetic vision are discussed.
Abbreviations
AIBSE |
Acute idiopathic blind spot enlargement |
AMD |
Age-related macular degeneration |
AZOOR |
Acute zonal occult outer retinopathy |
CBS |
Charles Bonnet syndrome |
fMRI |
Functional magnetic resonance imaging |
GA |
Geographic atrophy |
MEWDS |
Multiple evanescent white dot syndrome |
PIC |
Punctate inner choroidopathy |
PRL |
Preferred retinal locus |
RP |
Retinitis pigmentosa |
VEGF |
Vascular endothelial growth factor |
A.K. Bittner (*)
Lions Vision Research & Rehabilitation Center, Wilmer Eye Institute, Johns Hopkins University School of Medicine, 550 N. Broadway, 6th floor, Baltimore, MD 21205, USA
e-mail: abittne1@jhmi.edu
G. Dagnelie (ed.), Visual Prosthetics: Physiology, Bioengineering, Rehabilitation, |
93 |
DOI 10.1007/978-1-4419-0754-7_5, © Springer Science+Business Media, LLC 2011 |
|
